SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008194
Filing Date
2023-05-05
Accepted
2023-05-05 07:30:39
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 811398
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 14522
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 14545
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 7198
5 EX-32.2 tmb-20230331xex32d2.htm EX-32.2 7167
  Complete submission text file 0001558370-23-008194.txt   4359689

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230331.xsd EX-101.SCH 40629
7 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 38698
8 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 156362
9 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 348257
10 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 277295
57 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 602170
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 23891234
SIC: 2834 Pharmaceutical Preparations